Understanding Targeted Therapy And Immunotherapy Drugs For Techs

Targeted therapy and immunotherapy are revolutionary approaches in cancer treatment. They have transformed the landscape of oncology by offering more precise and effective options for patients. As healthcare technicians, understanding these therapies is essential to support patient care and treatment management.

What Is Targeted Therapy?

Targeted therapy involves drugs designed to specifically attack cancer cells by interfering with molecules involved in tumor growth and progression. These therapies are tailored to target unique genetic mutations or proteins expressed by cancer cells, minimizing damage to normal cells.

Common Types of Targeted Therapy Drugs

  • Tyrosine kinase inhibitors (e.g., imatinib, erlotinib)
  • Monoclonal antibodies (e.g., trastuzumab, rituximab)
  • Proteasome inhibitors (e.g., bortezomib)
  • PARP inhibitors (e.g., olaparib)

What Is Immunotherapy?

Immunotherapy harnesses the body’s immune system to recognize and destroy cancer cells. It enhances or restores the immune response, offering a different approach compared to traditional chemotherapy or radiation.

Types of Immunotherapy Drugs

  • Checkpoint inhibitors (e.g., pembrolizumab, nivolumab)
  • Cancer vaccines (e.g., sipuleucel-T)
  • Adoptive cell transfer (e.g., CAR T-cell therapy)
  • Cytokines (e.g., interleukins, interferons)

Role of Techs in Managing Targeted and Immunotherapy

Technicians play a vital role in administering these therapies, monitoring patient responses, and managing side effects. Proper preparation, patient education, and adherence to safety protocols are critical components of effective treatment delivery.

Monitoring and Support

  • Assessing patient vital signs and lab results
  • Managing infusion reactions
  • Educating patients about potential side effects
  • Reporting adverse events to healthcare providers

Conclusion

Understanding targeted therapy and immunotherapy drugs equips techs with the knowledge needed to support innovative cancer treatments. Staying informed about these therapies ensures better patient care and contributes to the success of modern oncology practices.